Brevan Howard Capital Management’s Cogent Biosciences COGT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$298K	Buy	+41,481	New	+$298K	﹤0.01%	1466
2024 Q3	–	Sell	-22,559	Closed	-$190K	–	1127
2024 Q2	$190K	Buy	+22,559	New	+$190K	﹤0.01%	853